Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines

During the COVID-19 pandemic, EPI-PHARE, a scientific group in pharmaco-epidemiology created by the French National Agency for the Safety of Medicines and Health Products (ANSM) and the French National Health Insurance (Cnam), has reoriented its work program to enlighten health authorities in this h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zureik, Mahmoud, Cuenot, François, Weill, Alain, Dray-Spira, Rosemary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique. 2023
Materias:
Pharmacoepidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851737/
https://www.ncbi.nlm.nih.gov/pubmed/36739224
http://dx.doi.org/10.1016/j.therap.2022.12.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851737/
https://www.ncbi.nlm.nih.gov/pubmed/36739224
http://dx.doi.org/10.1016/j.therap.2022.12.013

Ejemplares similares